Information and other resources to support commissioners, service providers and others providing alcohol and drug interventions (Public Health England)
Bibliography: Interventions – Harm Reduction
Environmental substance use prevention interventions in Europe
This report provides an overview of the range of environmental prevention interventions used in the substance use field and, based on a survey of prevention experts, paints a first picture of the extent to which environmental prevention measures are currently used in Europe as a starting point for future research (EMCDDA)
Fentanyl Overdose Reduction Checking Analysis Study (PDF)
FORECAST had three phases, conducted between April 2017 and November 2017: (1) evaluating drug checking technologies; (2) interviewing people who use drugs; and (3) interviewing key informants from organizations that work with people who use drugs (John Hopkins University – Bloomberg American Health Initiative)
Link Between Medical Marijuana and Fewer Opioid Deaths Is More Complex Than Previously Reported
The association between medical marijuana and lower levels of opioid overdose deaths—identified previously in several studies—is more complex than previously described and appears to be changing as both medical marijuana laws and the opioid crisis evolve, according to a new RAND Corporation study
Eliminating Hepatitis C in Scotland: A Call to Action
A summary of evidence from the Hepatitis C Elimination Inquiry held by the cross-party Scottish Hepatitis C Parliamentary Champions group and The Hepatitis C Trust
People powered recovery (PDF)
Social action and complex needs – Findings from a call for evidence (All-Party Parliamentary Group)
Minimizing Harm: Public Health and Justice System Responses to Drug Use and the Opioid Crisis (PDF)
How government and communities should respond to drug use is a perennial question that has gained a renewed sense of urgency in the face of the current opioid overdose crisis. More than 52,000 Americans died from a drug overdose in 2015, a number that has grown nearly ninefold since 1980 (Vera Institute of Justice)
Reducing the harm associated with drugs of abuse: the role of pharamacists (PDF)
This report represents the outcome of a literature search of a working group, their deliberations and insights (International Pharmaceutical Federation)
Harm reduction approaches predicted to reduce rates of new hepatitis C infection for people who inject drugs
Needle and syringe exchange appears to be cost-effective, especially if considering the health gains from preventing HIV transmission too. Although the evidence is from observational studies, and the extent of the benefit might uncertain, the nature of the topic makes it difficult to gather evidence in any other way and compared to the cost of treating the consequences of hepatitis later, seems good value (NIHR)
Preventing Opioid Overdose: Understanding Good Samaritan Laws
This tool supports these efforts by providing an overview of this overdose prevention strategy, including the aims of Good Samaritan laws and types of protections they can offer (SAMHSA)
National Naloxone Programme Scotland Monitoring Report 2016/17
This release from the Information Services Division presents information on the number of take-home naloxone kits issued by the National Naloxone Programme in Scotland (NHS Scotland)
Responding to the needs of ageing drug users
This paper outlines the main health and social issues for ageing drug users. The paper also outlines the interventions and initiatives currently being delivered in Europe to address these issues (EMCDDA)
User-led interventions: an expanding resource? (PDF)
Background paper commissioned by the EMCDDA for Health and social responses to drug problems: a European guide (EMCDDA)
Women who use drugs: Issues, needs, responses, challenges and implications for policy and practice (PDF)
Background paper commissioned by the EMCDDA for
Health and social responses to drug problems: a European guide
Fentanyl Report (PDF)
Report from a national round table discussion and recommendations for future action change, grow, live (CGL)
Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges
This paper was commissioned by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) to provide background information to inform and contribute to the drafting of Health and social responses to drug problems: a European guide
Evidence review summary: drug demand reduction, treatment, and harm reduction
This short report presents a brief overview of recent evidence for the most effective approaches in the fields of drug use prevention, drug use treatment and harm reduction (EMCDDA)
Recovery, reintegration, abstinence, harm reduction: the role of different goals within the drug treatment in the European context
The purpose of this paper is to discuss the different goals of ‘drug treatment’ within a European context and the key implications for those planning or delivering health and social responses (EMCDDA)
Exposure to substance use prevention messages amongst adolescents
This issue of The CBHSQ Report examines adolescents’ exposure to substance use prevention messages using data from the 2002 to 2015 NSDUHs (SAMHSA)
National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (PDF)
The 2017 annual report from the National Confidential Inquiry into Suicide and Homicide by People with Mental Illness (NCISH) provides findings relating to people who died by suicide or were convicted of homicide in 2005- 2015 across all UK countries
Drugs-related deaths rapid evidence review: Keeping people safe (PDF)
This report provides a synthesis of findings from the evidence based on the critical appraisal of systematic reviews and grey literature reports (NHSScotland)
Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWID in London (PDF)
These recommendations reflect those made by the LJWG in its publication Commissioning of hepatitis C (HCV) services in London for People Who Inject Drugs report from 2013 suggesting that there is still significant action and progress needed to increase access to HCV treatment.
The Evaluation of the Drug Recovery Wing Pilots (PDF)
In 2012, the Department of Health commissioned an evaluation of these pilots, which has been undertaken by researchers at the University of York, the Centre for Drug Use Research in Glasgow and the University of Cambridge
The opioid crisis in north America (PDF)
To mitigate the current crisis, the Global Commission on Drug Policy recommends:
The case for a national prescribed drug helpline (PDF)
All Party Parliamentary Group for Prescribed Drug Dependence
Psychoactive substances in secure mental health settings
This review summarises the latest evidence and makes recommendations for secure mental health service commissioners and providers (Public Health England)
A model drug law to 2020 and beyond
The key to moving towards an Aotearoa free from drug harm is to start treating drug use as a health issue rather than a criminal issue. Download (New Zealand Drug Foundation)
Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 (PDF)
The Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 (the Bill) seeks to amend the Drugs, Poisons and Controlled Substances Act 1981 (the Principal Act), to provide for the licencing and operation of a medically supervised injecting centre (MSIC) for a trial period of 18 months (Parliament of Victoria, Australia)
Still no harm reduction? (PDF)
A critical review of the UK Government’s new Drug Strategy (drugscience)
Widening the availability of naloxone
Updated 1 August 2017 (DoH)
Improving clinical responses to drug-related deaths (PDF)
A summary of best practice and innovations from drug treatment providers (NHS Substance Misuse Provider Alliance)
Hepatitis C Screening (PDF)
National Clinical Guideline (Irish Government)
3.1.4 People who use unprescribed or illicit drugs
3.1.5 Prisoners
3.1.6 People who are homeless
Preventing drug related deaths (PDF)
Drug-related deaths are rising and are a major concern to councils and our health partners. Deaths have increased sharply over the past five years and are now at their highest levels since records began. The reasons for the jump are varied. When Public Health England (PHE) and the Local Government Association (LGA) investigated it last year they came to a number of conclusions
Interim report prepared by White House Commission on Combating Drug Addiction and the Opioid Crisis
Recommendations for action (White House)
Take-home naloxone for opioid overdose in people who use drugs
Advice for local authorities and local partners on widening the availability of naloxone to reduce overdose deaths from heroin and other opiate drugs (Public Health England)
Widening the availability of naloxone
Naloxone is a prescription-only medicine and cannot therefore be sold over the counter. It can however be supplied without prescription by drug services. It can be used by anyone to save a life in an emergency (DoH)
Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States (National Academy of Sciences.)
Hepatitis C in England and the UK
Latest hepatitis C virus (HCV) reports, slide sets and infographics for England and the UK (Public Health England)
Reducing Harm, Supporting Recovery 2017 – 2025
Ireland’s “Reducing Harm, Supporting Recovery” strategy sets out the Government’s response to addressing the harm caused by substance misuse in our society over the next eight years. It identifies a set of key actions to be delivered between 2017 and 2020, and provides an opportunity for the development of further actions from 2021 to 2024 to address needs that may emerge later on in the lifetime of the strategy (DoH, Ireland)
2017 Drug Strategy (PDF)
This Strategy sets out clear expectations for action from a wide range of partners, including those in education, health, safeguarding, criminal justice, housing and employment (Home Office)
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 12
- Next Page »
